Skip to main content
Clinical Trials/IRCT20181002041210N1
IRCT20181002041210N1
Recruiting
Phase 1

Evaluation of sesame oral immunotherapy effect for desensitization in patients with sesame anaphylaxis

Iran University of Medical Sciences0 sites10 target enrollmentStarted: TBDLast updated:

Overview

Phase
Phase 1
Status
Recruiting
Enrollment
10

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
4 years to no limit (—)
Sex
All

Inclusion Criteria

  • positive oral food challenge with consumption of sesame tahini(OGHAB HALVA company) in patient with sesame anaphylaxis history with or without positive skin prick,skin prick to prick or specific IgE sesame tests

Exclusion Criteria

  • age less than 4 years
  • history of cardiovascular disease
  • beta blocker or ACEI drug usage
  • severe or uncontrolled asthma
  • infectious or immune deficiency disease
  • unwillingness of patient

Investigators

Similar Trials